various countries, some of which have high tuberculosis (TB) prevalence. O B J E C T I V E : To assess the predominant Mycobacterium tuberculosis strains in Israel isolated during 2008-2010 among Israeli-born and migrant patients, and to investigate possible transmission of TB from migrants to the local population.
M E T H O D S :
Molecular characterisation employed 43-spacer spoligotyping and 16-loci mycobacterial interspersed repetitive units-variable number of tandem repeats typing. All patients were classified according to those who were members of a cluster and those who were not. R E S U LT S : Along 684 M. tuberculosis strains isolated from new patients genotyped and assigned to their specific cohort populations during the study period, major spoligotype families were Central Asian (CAS) (n ¼ 140, 20%), Beijing (n ¼ 101, 15%) and T (n ¼ 160, 23%). Most Beijing strains (66%) were isolated from patients from the former Soviet Union (FSU), while CAS strains were mainly (74%) from Ethiopia, Eritrea and Sudan (EES). For the heterogeneous T-clade, patient countries of origin were 38% EES and 33% FSU. TUBERCULOSIS (TB) is a major cause of global morbidity and death. Although Israel receives migrants from developing countries, TB incidence in Israel remains low, with 4.3 adult cases per 100 000 population in 2010; this is considered low on the global scale. 1 The 1999-2010 average annual TB rates among Israeli-born citizens, foreign-born citizens and foreign-born non-citizens were respectively 0.86, 11.9 and 27/100 000. 2 Israel is an industrialised country with a gross domestic product of US$29 800 per person and a population of~8 million. Almost 2.5 million of its citizens were born outside Israel, of whom about 200 000 are migrant non-Israeli citizens who arrived mostly for work from high TB prevalence countries. A significant recent influx occurred when~50 000 migrant non-Israeli citizens arrived from Eritrea, Ethiopia and Sudan (EES) from 2006, while approximately 1 million Jewish migrants have arrived from the former Soviet Union (FSU) since 1990, and~70 000 Jewish migrants have arrived from Ethiopia since 1985. Migrants of Jewish descent are considered homecomers, are naturalised upon arrival and are entitled to all civil rights, including health insurance, from the day of arrival. 3, 4 Like Israeli citizens, migrant non-Israeli citizens receive cover for TB diagnosis and treatment. Costs are reimbursed directly to the TB clinics by the Ministry of Health. These migrants usually live in segregated neighbourhoods and are generally not assimilated into Israeli society. 3, 5 Physicians and laboratories are required to notify TB cases and individuals presumed to have TB to the Ministry of Health. Upon notification, the local health department conducts epidemiological investigations to identify the index case and locate the patient's contacts. All patients are treated in one governmental hospital ward and nine community TB clinics by supervised directly observed therapy (DOT) for the entire treatment period, which lasts for a minimum of 6 months. 2, 3 Correspondence to: Paul J Freidlin, National Mycobacterium Reference Laboratory, National Sputum and tissue samples are sent to designated laboratories, including the National Mycobacterium Reference Laboratory (NMRL) in Tel Aviv, Israel, for culture and drug susceptibility testing (DST). All Mycobacterium tuberculosis isolates cultured in Israel are sent to the NMRL for genotypic testing. The NMRL uses both 43-spacer spoligotyping and 16-loci mycobacterial interspersed repetitive unitsvariable number of tandem repeats (MIRU-VNTR) techniques. Spoligotyping has been widely used in investigating the population structure of M. tuberculosis, focusing on the identification of genotypic lineages, spoligotype families and their geographic distribution. 6 In combination with 43-spacer spoligotyping, MIRU-VNTR typing can be used to cluster M. tuberculosis strains from patients with epidemiological links, identify chains of transmission and discriminate isolates at the clonal level. 7 The aims of the present study were to 1) describe the available strains in Israel between 2008 and 2010, 2) characterise the prevalence of M. tuberculosis strains in different populations, and 3) assess the penetration of imported isolates to the local Israeli population.
MATERIALS AND METHODS
All new culture-positive strains collected during 2008-2010 were analysed. Cultures were performed using both liquid (BACTECe MGITe 960; BD, Sparks, MD, USA) and solid (Löwenstein-Jensen) media. Commercial DST results were confirmed and expanded using the resistance ratio method. 8 Genotyping was performed at the NMRL using 43-spacer spoligotyping 6 and 16-loci MIRU-VNTR typing 9 to characterise the genetic diversity of the M. tuberculosis strains. Of all 741 new culture-positive samples, 684 (92%) were genotyped and entered in Bionumerics, version 3.5 (Applied Maths, Sint-MartensLatem, Belgium) databases. Clustering with Bionumerics used categorical coefficients and the UPGMA (unweighted pair group method with arithmetic mean) dendrogram. Clusters were defined as strains that were identical using 16-loci MIRU-VNTR typing and 43-spacer spoligotyping. Clades (families) were defined according to spoligotyping patterns, as described in SpolDB4. 10 'Mixed clusters' were defined as clusters of mycobacteria isolated from Israeli-born and non-Israeli born patients (both Israeli and non-Israeli citizens). Israeli-born patients belonging to mixed clusters were asked if they could recall possible contact with a non-Israeli-born individual. In addition, data were retrieved from files on epidemiological investigations performed by the health departments at the time of notification.
For the bivariate analysis of those classified as members of a cluster and those who were not, categorical and continuous variables were compared using the v 2 and Student's t-tests, respectively. P , 0.05 was considered statistically significant. Multivariable logistic regression was used to identify characteristics predicting membership of a cluster using the backward technique after assessing for colinearity and normal distribution, generating odds ratios (ORs) and 95% confidence intervals (95%CIs). Analyses were performed using SPSS w , version 19.0 (Statistical Product and Service Solutions, Chicago, IL, USA).
The study was approved by the Institutional Review Board of the Edith Wolfson Medical Center, Tel Aviv, Israel (WOMC-0083-11).
RESULTS
Between 2008 and 2010, 779 (76.7%) new pulmonary TB and 237 (23.3%) extra-pulmonary TB patients were reported in Israel. Bacteriological confirmation was obtained from 741 (72.9%) patients; of these, 684 (92.3%) were further characterised using spoligotyping and MIRU-VNTR; 587 (86%) showed spoligotypes described in the international SpolDB4 database 10 and SITVIT, 11 while 97 (14%) showed unidentified patterns (designated NIS, or not internationally identified spoligotype).
Molecular epidemiology mapping
The main spoligotyping families were Central Asian (CAS), Beijing and T. Most of the patients infected with the Beijing strains (66%) originated from the FSU countries; only 2% originated from EES. Most of the patients infected with the CAS strains originated from EES (73%); only 4% originated from FSU countries ( Table 1) . Of the CAS family, CAS1_Delhi SIT 25, known in our laboratory as PETRA (polymorphic exact tandem repeat A), 12 predominated (46%), with 89% originating from EES (data not shown). The T-clade was found to be more heterogeneous, with isolates from patients arriving from both FSU (33%) and EES (38%).
Only 29 multidrug-resistant TB (MDR-TB, defined as resistance to at least isoniazid and rifampicin) cases (4%) were found during the study period. Of these, 20 were from the Beijing family, 4 from LAM9, 1 from T5_RUS1 and 4 from T3_ETH.
Characterisation of migrants without citizenship
During the study period, 221 (32%) of the 1016 TB patients identified were migrants without Israeli citizenship. The predominant TB strains among these were of the CAS spoligotype lineage (32%,), most of which (80%) originated from EES; 16% belonged to the T-clade, most of which (83%) originated from EES; 6% belonged to the Haarlem and 8% to the LAM families, with respectively 64% and 50% originating from EES; 8% belonged to the Beijing family, of which only 11% originated from EES (Table 1 and the Figure) .
Cluster analysis
Of all the genotyped strains, 336 (49%) were grouped into 83 clusters, including 15 Beijing clusters. Each cluster included between 2 and 26 patients. Using univariate analysis of all the study population, membership of a cluster was found to be more common in the younger age group, among males, migrant citizens from Ethiopia, migrants who had been in Israel for longer, those with human immunodeficiency virus (HIV) co-infection and those with positive sputum and MDR-TB strains. The mortality rate among cluster members was higher than in non-clustered members (Table 2) . In multivariate analysis, younger age, male sex, citizens born in Ethiopia, migrants with longer residence in Israel, smear positivity and MDR-TB were predictive of membership of a cluster. While younger age and MDR-TB were predictive of cluster membership among Israeli-born patients (Appendix Table A .2). Membership of a cluster also reflected the time the migrant had spent in Israel. For example, Israeli citizens originating from the FSU or Ethiopia had a greater risk of being part of a cluster if they had stayed .2 years in Israel than those who had arrived ,2 years previously (respectively 50.3% vs. 15.0% for FSU, 23.2% vs. 13.9% for Ethiopians), while migrant non-Israeli citizens who were born in EES had a greater risk of being members of a cluster if they had been ,2 years in Israel than those who had arrived .2 years previously (48.1% vs. 1.2%, respectively, P , 0.01).
Of all 83 clusters, 30 (36%) were 'mixed' clusters, which included Israeli and non-Israeli born (Israeli and non-Israeli citizens); 12 of these were composed of both Israeli and non-Israeli citizens (Appendix Table A. 3). Although the largest mixed cluster was Beijing, only three of these cases (11.5%) were nonIsraeli citizens.
Of the 40 Israeli-born patients included in mixed clusters, 24 (55.8%) shared the cluster only with nonIsraeli born citizens, 12 (27.9%) shared the cluster with both non-Israeli-born citizens and non-Israeliborn non-citizens and 4 (9.3%) shared the cluster with non-Israeli-born non-citizens. Of all the Israeliborn patients, none recalled having had contact with a known TB patient; 15 could recall close contact with a non-Israeli-born citizen, but not with a non- Israeli-born non-citizen. Of these 25 Israeli-born patients with no recollection of any contact, 6 (24%) shared the cluster with both non-Israeli-born citizens and non-citizens, 15 (60%) with non-Israeliborn citizens and 4 (16%) with non-Israeli-born noncitizens. None of the Israeli-born patients could recall close contact with an individual born in the EES, such as sharing a household, place of work or a social or commercial gathering.
DISCUSSION
In this study, three predominant families were found in Israel: CAS, T and Beijing. Distribution of these M. tuberculosis families reflected the patients' countries of origin: most patients with the Beijing strain originated from FSU, most patients with CAS from EES and patients with the heterogeneous T-clade originating from both EES (38%) and FSU (33%). Among all cases, four (0.6%) Israeli-born patients shared clusters with non-Israeli-born non-citizens, but no cases of transmission were confirmed by epidemiological investigation. Our results suggest that the CAS family constitutes the predominant family of M. tuberculosis strains among migrants from EES, while the most significant spoligotype pattern was the CAS1_Delhi SIT 25, which was previously designated as PETRA in Israel. 12 These findings are in agreement with another publication 13 that reported that the CAS1_Delhi family (SIT25) was shared by 35% of strains in Sudan. The predominance of the Delhi/CAS lineage was also described in north-west Ethiopia, 14 where M. tuberculosis Delhi/CAS accounts for 39% of the strains investigated. In another study from Addis Ababa, 43.5% of the strains in this area are of CAS lineage. 15 T-clade is more heterogeneous in Israel, with 38% of isolates being from patients who originated in EES; this is in line with studies from Ethiopia. [15] [16] [17] Among T-family strains, T3_ETH was found to be predominant in Ethiopia and was possibly involved in the emergence of MDR-TB. 15 In our study, T3_ETH included drug-resistant and MDR-TB strains, as opposed to all other typical recent strains of African origin in Israel, which were susceptible to antituberculosis drugs.
Despite the presence of predominant shared molecular patterns, the diversity of M. tuberculosis strains found in Israel is high, reflecting the demographic heterogeneity of Israeli TB patients, and particularly their countries of origin, as most were non-Israeli-born. High genetic diversity was already observed in the first molecular epidemiology study of M. tuberculosis conducted in the 1990s in Israel using insertion sequence 6110 restriction fragment length polymorphism analysis. 18 In this study, while the T and CAS families were characteristic of patients originating from EES countries, the Beijing strains were characteristic of patients who had arrived from the FSU and had the highest rate of MDR-TB cases. This is in agreement with other publications, indicating that the M. tuberculosis Beijing strains are an evolving lineage of M. tuberculosis that had acquired drug resistance. [19] [20] [21] [22] However, it has been reported that the association between this genotype and drug resistance varies in different countries. 23, 24 Like other industrialised countries, Israel faces challenges pertaining to migration from developing countries. It is often argued that these migrants have the potential to expose the local population in the host country to infectious diseases such as TB. However, this study demonstrates that only limited transmission occurred from migrants to the local population. Most of the Israeli-born patients who were members of mixed local-foreign clusters were in close contact with Ethiopian-born patients (who were all Israeli citizens) or had visited high TB prevalence countries. None of the Israeli citizens could recall contact with migrant non-Israeli citizens. Furthermore, the high proportion of M. tuberculosis strain clustering among migrants suggested that transmission may have occurred mostly among foreign-born communities rather than among locals. These findings are in line with other publications from other industrialised countries reporting limited transmission of M. tuberculosis from migrant workers to local citizens. 25 To contain TB transmission among migrants, the public health response should be rapid, particularly among young patients from EES, and should include patient isolation and contact investigations. Public health officials can also use this information showing limited transmission from migrants to the general population to change the existing xenophobic climate against migrants as being a possible source of infection.
Of all isolates in our study, 336 (49%) were clustered, more than the previous proportions reported from Israel 18 and those reported from the Netherlands, 26 Switzerland, 27 Denmark, 28 Germany, 29, 30 England 31 and Italy. 32, 33 The high level of clustering observed in Israel among migrants originating from EES countries may reflect reactivation among nonIsraeli-born patients of infection by TB strains that were common in their countries of origin rather than the acquisition of new infection in Israel. According to a recent report describing the molecular epidemiology of TB in Ethiopia, 14 45 .1% of isolates in Ethiopia are grouped in clusters. The likelihood of reactivation of latent infection rather than recent transmission is also reinforced by the fact that most of the members who shared the same cluster did not recall epidemiological connections with a known TB patient, despite thorough epidemiological investigations. It was therefore uncommon for Israeli-born patients to belong to a cluster populated with patients //xinet/production/j/jtld/live_jobs/jtld-18-09/jtld-18-09-19/layouts/jtld-18-09-19.3d 7 July 2014 10:30 pm Allen Press, Inc. 0186from the EES, as they did not report close friends in these groups and were not family members.
This study is subject to several limitations. First, we might have overestimated the clustering rate by analysing Beijing clusters using 16 MIRU-VNTR loci, rather than the more discriminatory 24 MIRU-VNTR loci. 35 From a brief estimation for 2010, we found that while the clustering estimation on the basis of 43-spacer spoligotyping and 16-loci MIRU-VNTR typing was 41%, calculation on the basis of 24 MIRU-VNTR loci and 43-spacer spoligotyping indicated only 32% clustering. Second, 8% of bacteriological samples could not be genotyped due to technical problems which led to their random exclusion.
CONCLUSIONS
Mapping by genotyping of M. tuberculosis strains in Israel is consistent with the demographic epidemiology of TB in Israel, as it is mostly concentrated among migrants (both Israeli and non-Israeli citizens) from countries with high TB prevalence. Cluster analysis based on MIRU-VNTR typing and spoligotypes indicated that Israeli citizens who originated from Ethiopia, as well as non-Israeli citizens from Sudan or Eritrea, showed a higher risk of belonging to a cluster than Israeli-born citizens. Finally, despite thorough epidemiological investigations, most of the members who shared the same cluster did not show epidemiological connections with a known TB patient. Se practicó la caracterización molecular de las cepas mediante el espoligotipado con 43 espaciadores y la genotipificación con marcadores para 16 locus múltiples de secuencias repetitivas en tá ndem. Todas las cepas se clasificaron según su pertenencia o no a un conglomerado. R E S U L T A D O S: Durante el período del estudio, se aislaron 684 cepas de M. tuberculosis de los casos nuevos, las cuales se genotipificaron y se asignaron a las cohortes de población específicas. Las familias de micobacterias detectadas con mayor frecuencia en Israel mediante el espoligotipado fueron: la de Asia central (n ¼ 140; 20%), la familia Beijing (n ¼ 101; 15%) y la familia T (n ¼ 160; 23%). La mayoría de las cepas Beijing (66%) se aisló de pacientes provenientes de la antigua Unión Soviética y los pacientes con cepas de la familia de Asia central provenían principalmente de Etiopía, Eritrea y Sudá n (74%). Con respecto clado T de origen heterogéneo, los pacientes provenían de Etiopía, Eritrea y Sudá n en un 38% y un 33% de la antigua Unión Soviética. C O N C L U S I Ó N: Los genotipos de M. tuberculosis predominantes en Israel entre el 2008 y el 2010 fueron semejantes a los genotipos endémicos en los países de origen de los inmigrantes. Las investigaciones epidemiológicas no pusieron en evidencia una transmisión de la TB de los inmigrantes hacia los pacientes nacidos en Israel que compartían el mismo conglomerado.
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